Literature DB >> 36267788

Is prognosis uniformly excellent in patients with stage II MSI-high colon cancer?

Jane Wang1, Georgios Antonios Margonis2,3.   

Abstract

Entities:  

Year:  2022        PMID: 36267788      PMCID: PMC9577717          DOI: 10.21037/atm-22-3481

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  4 in total

1.  Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.

Authors:  David S Williams; Dmitri Mouradov; Robert N Jorissen; Marsali R Newman; Elham Amini; David K Nickless; Julie A Teague; Catherine G Fang; Michelle Palmieri; Marie J Parsons; Anuratha Sakthianandeswaren; Shan Li; Robyn L Ward; Nicholas J Hawkins; Ian Faragher; Ian T Jones; Peter Gibbs; Oliver M Sieber
Journal:  Gut       Date:  2018-01-30       Impact factor: 23.059

2.  High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.

Authors:  Amr Mohamed; Renjian Jiang; Philip A Philip; Maria Diab; Madhusmita Behera; Christina Wu; Olatunji Alese; Walid L Shaib; Tyra M Gaines; Glen G Balch; Bassel F El-Rayes; Mehmet Akce
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

3.  Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study.

Authors:  Yuting Zhang; Zehua Wu; Bin Zhang; Huabin Hu; Jianwei Zhang; Yi Chen; Miaomiao Ding; Yabing Cao; Yanhong Deng
Journal:  Ann Transl Med       Date:  2022-06

4.  Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features?

Authors:  Paul M Cavallaro; Caitlin Stafford; Christy E Cauley; David L Berger; Liliana Bordeianou; Hiroko Kunitake; Todd Francone; Rocco Ricciardi
Journal:  Dis Colon Rectum       Date:  2021-05       Impact factor: 4.585

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.